Related Experiment Video
Updated: Mar 23, 2026

Author Spotlight: Translational Applications of Stimulated SFEMG in Rodent Models
Published on: March 8, 2024
[Comparison of neostigmine induced reversal of rocuronium in different age children]
1Department of Anesthesiology, Tianjin Children's Hospital, Clinical Pediatric College of Tianjin Medical University, Tianjin 300134, China.
Insights
Neostigmine effectively reverses rocuronium-induced neuromuscular blockade in pediatric patients. However, neonates experience longer recovery times compared to infants, young children, and older children, indicating age-related differences in drug response.
Area of Science:
- Anesthesiology
- Pediatric Pharmacology
- Neuromuscular Blockade
Background:
- Rocuronium is a common neuromuscular blocking agent used in pediatric surgery.
- Understanding age-specific recovery from neuromuscular blockade is crucial for patient safety.
- Neostigmine is a standard reversal agent for neuromuscular blockade.
Purpose of the Study:
- To compare the effectiveness of neostigmine in reversing rocuronium-induced neuromuscular blockade across different pediatric age groups.
- To evaluate age-related differences in spontaneous and neostigmine-induced recovery times.
Main Methods:
- A study involving 160 pediatric patients undergoing elective surgery.
- Patients were divided into four age groups: neonates, infants, young children, and children.
- Neuromuscular block was monitored using acceleromyography; neostigmine or saline was administered for reversal.
Main Results:
- Spontaneous recovery times (T75, TR0.7, recovery index) were significantly longer in neonates compared to other age groups.
- Neostigmine effectively reversed rocuronium-induced blockade in all age groups.
- Recovery times following neostigmine administration were also longer in neonates than in infants, young children, and children.
Conclusions:
- Spontaneous recovery from rocuronium is comparable among infants, young children, and children.
- Neostigmine demonstrates significant reversal effects across all pediatric age groups.
- Neonates exhibit prolonged spontaneous and neostigmine-reversed recovery times from rocuronium compared to older pediatric populations.
Objective:
To compare the effectiveness of neostigmine induced reversal of rocuronium in neonates, infants, young children and children.
Methods:
One hundred and sixty ASA I or II pediatric patients undergoings elective surgical procedures under total intravenous anesthesia were enrolled during July 2014 to April 2015 in Tianjin Children's Hospital. The patients were divided into four groups according to ages: neonate group, infant group, young children group and children group.Then control subgroup and neostigmine reversal subgroup including twenty patients were randomly selected from every different age groups by the method of random number table. After induction of anesthesia, 0.6 mg/kg rocuronium was administered, and 0.2 mg/kg maintenance doses given as required during period of operation. Neuromuscular block was monitored using acceleromyographic train of four (TOF). When T1/control returned to 15%, 0.03 mg/kg neostigmine and 0.01 mg/kg atropine were given to patients of reversal subgroups, and saline 0.1 ml/kg was given to patients of control subgroups. The recovery time of T25, T75, TR0.7, recovery index, blood pressure, heart rate and adverse reactions were observed and recorded.
Results:
In control subgroups, the recovery time of T75 for neonates, infants, young children and children were (27.10±8.72), (16.70±6.35), (13.05±1.96), (14.40±3.08) min, respectively (F=25.052, P<0.01). The recovery time of TR0.7 were (27.75±8.56), (18.45±5.62), (14.95±2.64), (15.70±3.36) min, respectively (F=22.496, P<0.01). The recovery index were (20.75±7.09), (12.40±5.04), (10.01±2.00), (10.55±2.82) min, respectively (F=22.725, P<0.01). There were no significant difference for the every recovery time and recovery index between infants, young children and children (all P>0.05). But the recovery time of T75, TR0.7 and recovery index in neonate group were longer than other age groups (all P<0.01). In reversal subgroups , the recovery time of T75 for neonates, infants, young children and children were (14.05±3.54), (8.08±3.08), (6.53±0.98), (7.10±1.54) min, respectively (F=37.947, P<0.01). The recovery time of TR0.7 were (14.95±3.19), (9.32±3.44), (7.45±1.40), (8.12±1.67) min, respectively (F=34.744, P<0.01). The recovery index were (11.05±3.26), (5.96±2.46), (4.99±0.95), (5.22±1.39) min, respectively (F=33.542, P<0.01). The recovery time of T75, TR0.7 and recovery index were delayed in neonates compared with other age groups (all P<0.01). Haemodynamics were stable in all groups before or after giving antagonist, and no significant adverse reactions were observed.
Conclusions:
The spontaneous recovery time after administrating rocuronium are comparable in infant, young children and children. There are obviously reversal effects in all of age groups when neostigmine is given to antagonize rocuronium. Either spontaneous recovery time or reversal recovery time of neostigmine to rocuronium is longer for neonates than other age's children.
Related Concept Videos
Skeletal Muscle Relaxants: Therapeutic Uses
Indirect-Acting Cholinergic Agonists: Pharmacokinetics
Reversible agents containing quaternary amines, such as neostigmine and edrophonium, are not easily absorbed orally because they...
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Nondepolarizing (Competitive) Neuromuscular Blockers: Mechanism of Action
Competitive antagonists prevent acetylcholine from binding to its receptor, inhibiting membrane depolarization. Without conformational changes or intrinsic...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

